Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NDC1 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
mRNA | ALMS1 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | UBTD1 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-06 |
mRNA | STK32A | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-06 |
mRNA | PHIP | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | NUP155 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | CAMSAP1 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | MFAP5 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-06 |
mRNA | LRRC32 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-06 |
mRNA | RNF126 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |